Wegovy 1.7mg: what real before-and-after experiences look like at this dose

You've just increased to 1.7mg and you're wondering what's normal

Picture this: you collected your 1.7mg pen on a Monday, injected that evening, and by Wednesday you're wondering whether the mild nausea is a bad sign or just the expected bump after stepping up. It's almost certainly the latter. Every time the Wegovy dose increases, the body needs a short settling period (usually a few days to a couple of weeks) before the new level feels comfortable. That pattern tends to be most pronounced in the early steps and somewhat less dramatic by 1.7mg, because most people's digestive systems have already adapted to semaglutide being in the picture.

What people typically describe at this stage is a sense of the medicine becoming more present. Hunger, which at 0.5mg or 1mg might have quietened only modestly, tends to feel more clearly blunted. Thoughts about food between meals become less insistent. Some people notice they're leaving food on the plate more consistently, or that a smaller lunch keeps them comfortable until the early evening without much effort. That said, individual responses differ considerably, and some people at 1.7mg still feel they're waiting for the medicine to really land, that can be normal too, and the step to 2.4mg often resolves it. You can read about what people report at the 2.4mg maintenance dose if you're trying to calibrate where you're heading.

The NHS patient information for semaglutide explains the full side-effect profile across all doses, and it's worth revisiting the NHS semaglutide medicines page if anything feels unfamiliar or new at this stage.

Before 1.7mg: what the earlier steps tend to set up

The Wegovy titration schedule (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg) is designed deliberately slowly. The early doses aren't meant to produce substantial weight loss on their own; their job is to acclimatise your system so that the therapeutic doses are tolerable. If you're comparing notes with someone else and they lost more at 0.5mg than you did, that doesn't mean your treatment isn't working.

By the time most people reach 1.7mg, they've usually had their first experience of what reduced appetite actually feels like on this medicine, even if it's been subtle. Some describe the earlier steps as feeling like nothing much changed; others noticed a clear difference from week two or three. Both are reported in the wider community of people on this treatment. If you want a sense of what the 0.5mg or 1mg steps felt like for others, the 0.5mg Wegovy experience page and the 1mg Wegovy reviews page cover those steps in detail.

The practical context for 1.7mg is that you're close to the end of the titration process. Most people reach this dose around the three-month mark if they've followed the standard four-weekly schedule without needing to pause. Whether the dose increases on time or slows down is always your prescriber's call based on your response and tolerability, not a target to chase.

After 1.7mg: what moving to 2.4mg tends to change

The step from 1.7mg to 2.4mg is the final one in the standard schedule, and for many people it's where the full appetite-suppressing effect of Wegovy becomes most apparent. Clinical trial data from the STEP 1 study, published in the New England Journal of Medicine, found that adults taking semaglutide 2.4mg alongside lifestyle changes lost an average of around 15% of body weight over 68 weeks. That figure reflects the full treatment course, including all the titration steps, not any single dose in isolation.

What people often describe after moving from 1.7mg to 2.4mg is a further step down in baseline hunger rather than a dramatic overnight shift. Portion sizes feel comfortable at a smaller volume. Energy levels can feel more stable through the day for some people, though this isn't universal. The question of whether higher doses work better for everyone is worth exploring through the evidence on Wegovy dose and effect.

If you're thinking about the cost of staying on treatment through to maintenance dose and beyond, the Wegovy price comparison page sets out what private treatment typically costs in the UK and what a legitimate price should include. It's also worth knowing that the full Wegovy dose schedule explains not just the steps but the rationale behind the pacing, useful reading before your next prescriber review.

What matters most when reviewing your own progress at this stage

Before-and-after accounts online can be reassuring, but they can also skew your expectations if the people sharing them had unusually smooth experiences or particularly fast results. The honest picture is that 1.7mg is a transitional step, and most of the measurable weight-loss data accumulates over months, not weeks. A question our prescribers hear fairly regularly is whether a person should be losing more by now, and the answer almost always involves looking at the whole picture: how long they've been on treatment, whether lifestyle changes are running alongside it, any medicines or conditions that affect response.

If you're checking your progress between clinical reviews, the most useful thing to track is the trend over four-week blocks rather than week-to-week variation. Body weight fluctuates day to day for reasons unrelated to semaglutide, water retention, time of the month, a particularly salty dinner. What matters is the direction over time.

Wegovy is a prescription medicine assessed individually by a clinician. If you're curious about whether you're on track or what the next steps look like, the free consultation at nume connects you with a GPhC-registered prescriber who reviews your case personally. You can also read more about how Wegovy works as a treatment or explore the broader weight-loss treatment options if you're still deciding which path suits you.